Georgia Life Sciences Summit Company Showcase — Applications Now Being Accepted

We are pleased to invite applications for company presentations at the Georgia Life Sciences Summit taking place on August 26-27 at the Sandy Springs Performing Arts Center. This is a unique opportunity for innovative life sciences companies to showcase their work to an audience of more than 300+ investors, industry leaders, researchers, and decision-makers. Presenting companies will benefit from high visibility, presentation feedback from a panel of advisors, targeted networking opportunities, and potential partnerships.

Eligibility

We welcome applications from Georgia-based companies operating in agriculture, biotechnology, pharmaceuticals, diagnostics, digital health, medical devices, and other life sciences sectors. Companies should have a validated proof-of-concept or market-ready prototype, a clear commercialization plan with milestones, and legal ownership of technology.

Presentation Details

The format includes a 3-minute presentation followed by a 2-minute Q&A. The audience will consist of investors, corporate executives, researchers, and media. The application deadline is June 30.

Apply now to secure your spot in this year’s showcase!

For questions, contact Stacey Bowlin at sbowlin@galifesciences.org.

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.